Related references
Note: Only part of the references are listed.Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice
Jia Huang et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2021)
Involvement of PTEN and FOXO3a Proteins in the Protective Activity of Protocatechuic Acid Against Cisplatin-Induced Ovarian Toxicity in Mice
Bruna Bortoloni Gouveia et al.
REPRODUCTIVE SCIENCES (2021)
Rutin prevents cisplatin-induced ovarian damage via antioxidant activity and regulation of PTEN and FOXO3a phosphorylation in mouse model
Thae Lanne B. G. Lins et al.
REPRODUCTIVE TOXICOLOGY (2020)
AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice
Charlotte Sonigo et al.
FASEB JOURNAL (2019)
Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide
Yi Luan et al.
JOURNAL OF ENDOCRINOLOGY (2019)
Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation
Wessam M. Abdel-Wahab et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
Mehri Jamilian et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway
Arisa Takeuchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility
Giovanna Bellusci et al.
CELL DEATH & DISEASE (2019)
Melatonin regulates the activities of ovary and delays the fertility decline in female animals via MT1/AMPK pathway
Lu Zhang et al.
JOURNAL OF PINEAL RESEARCH (2019)
Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model
Rauf Melekoglu et al.
JOURNAL OF OVARIAN RESEARCH (2018)
The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide
Bao-fang Zhang et al.
PLOS ONE (2018)
Melatonin-mediated upregulation of Sirt3 attenuates sodium fluoride-induced hepatotoxicity by activating the MT1-PI3K/AKT-PGC-1α signaling pathway
Chao Song et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles
Hoon Jang et al.
JOURNAL OF PINEAL RESEARCH (2017)
Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo
Linyan Zhou et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity
Ricassio S. Barberino et al.
BIOLOGY OF REPRODUCTION (2017)
Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary
Hoon Jang et al.
JOURNAL OF PINEAL RESEARCH (2016)
Follicle Loss and Apoptosis in Cyclophosphamide-Treated Mice: What's the Matter?
Xiu-Ying Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Tamoxifen Prevents Apoptosis and Follicle Loss from Cyclophosphamide in Cultured Rat Ovaries
Joanna Piasecka-Srader et al.
BIOLOGY OF REPRODUCTION (2015)
Protective effect of mirtazapine and hesperidin on cyclophosphamide-induced oxidative damage and infertility in rat ovaries
Naglaa Fathi Khedr
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Protective effects of Eugenia jambolana extract versus N-acetyl cysteine against cisplatin-induced damage in rat testis
H. Anand et al.
ANDROLOGIA (2015)
Clinical relevance of melatonin in ovarian and placental physiology: a review
Russel J. Reiter et al.
GYNECOLOGICAL ENDOCRINOLOGY (2014)
Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice
A. Chabra et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
Essential actions of melatonin in protecting the ovary from oxidative damage
M. H. C. Cruz et al.
THERIOGENOLOGY (2014)
Prophylactic Efficacy of Melatonin on Cyclophosphamide-Induced Liver Toxicity in Mice
Mohammad Shokrzadeh et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A preclinical study on the protective effect of melatonin against methotrexate-induced small intestinal damage: effect mediated by attenuation of nitrosative stress, protein tyrosine nitration, and PARP activation
Viswa Kalyan Kolli et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Peripheral Reproductive Organ Health and Melatonin: Ready for Prime Time
Russel J. Reiter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cyclophosphamide Triggers Follicle Activation and Burnout; AS101 Prevents Follicle Loss and Preserves Fertility
Lital Kalich-Philosoph et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Melatonin as Adjuvant Cancer Care With and Without Chemotherapy: A Systematic Review and Meta-analysis of Randomized Trials
Dugald Seely et al.
INTEGRATIVE CANCER THERAPIES (2012)
Toxicity of Chemotherapy and Radiation on Female Reproduction
Dror Meirow et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2010)
Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway
Sara Casado-Zapico et al.
JOURNAL OF PINEAL RESEARCH (2010)
Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool
Pradeep Reddy et al.
SCIENCE (2008)
Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention
Chun W. Tam et al.
JOURNAL OF PINEAL RESEARCH (2007)
Functional MT1 and MT2 melatonin receptors in mammals
ML Dubocovich et al.
ENDOCRINE (2005)
N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals
I Medved et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Is there a role for melatonin in supportive care?
P Lissoni
SUPPORTIVE CARE IN CANCER (2002)
Share Paper
